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Role of cytokines in Trypanosoma brucei-induced 
anaemia: A review of the literature
                         Abstract
Background 
Anaemia is an important complication of  trypanosomiasis. The 
mechanisms through which trypanosomal infection leads to anaemia 
are poorly defined. A number of  studies have implicated inflammatory 
cytokines, but these data are limited and inconsistent. In this article, we 
reviewed the published literature on cytokines associated with Trypanosoma 
brucei infections and their role in the immunopathology leading to anaemia. 
Methodology
Articles were searched in PubMed through screening of  titles and abstracts 
with no limitation on date of  publishing and study design. Articles 
in English were searched using keywords “African trypanosomiasis”, 
“sleeping sickness”, “Trypanosoma brucei”, in all possible combinations with 
“anaemia” and/or “cytokines”.
Results
Twelve articles examining cytokines and their role in trypanosome-
induced anaemia were identified out of  1095 originally retrieved from 
PubMed.  None of  the articles identified were from human-based studies. 
A total of  eight cytokines were implicated, with four cytokines (IFN-γ, 
IL-10, TNF-α, IL-12) showing an association with anaemia. These articles 
reported that mice lacking TNF-α were able to control anaemia, and 
that IFN-γ was linked to severe anaemia given its capacity to suppress 
erythropoiesis, while IL-10 was shown to regulate IFN-γ and TNF-α, 
providing a balance that was associated with severity of  anaemia. IFN-γ 
and TNF-α have also been reported to work in concert with other factors 
such as nitric oxide and iron in order to induce anaemia.
Conclusion
IFN-γ, IL-10, and TNF-α were the three major cytokines identified to be 
heavily involved in anaemia caused by Trypanosoma brucei infection. The 
anti-inflammatory cytokine, IL-10, was shown to counter the effects of  
proinflammatory cytokines in order to balance the severity of  anaemia. 
The mechanism of  anaemia is multifactorial and therefore requires 
further, more elaborate research. Data from human subjects would also 
shed more light.
Introduction
The protozoan parasites that cause trypanosomiasis, 
also known as sleeping sickness in humans and nagana in 
animals in Africa, are extracellular haemoflagellates of  the 
species Trypanosoma brucei that are transmitted by a tsetse 
fly (Glossina spp.) bite. Other important species causing 
nagana that circulate alongside Trypanosoma brucei include 
Trypanosoma vivax and Trypanosoma congolense. Infection from 
the subspecies Trypanosoma brucei gambiense, typically found in 
western and central Africa, can progress (over a few months 
to over several years) from the haemolymphatic stage, 
during which the parasites are in the peripheral blood, to 
the meningoencephalitic stage, after the trypanosomes cross 
the blood-brain barrier. The subspecies Trypanosoma brucei 
rhodesiense in eastern and southern Africa generally causes 
a more acute form of  human African trypanosomiasis 
(HAT). Presently 98% of  all reported HAT cases are caused 
by Trypanosome brucei gambiense1. Trypanosoma brucei brucei is 
sensitive to trypanolytic factors present in human serum and 
therefore fails to establish infection in humans. T. brucei brucei 
can, however, cause disease in some livestock2. The disease 
runs a complex course leading to death if  left untreated in 
both animals and humans.
Though HAT is a well-known parasitic infection with 
neurological involvement, the most common complication 
associated with it is anaemia. Anaemia occurs in humans, 
livestock3,4 and experimental mouse models5–7. In 
humans, anaemia is the common characteristic during the 
haemolymphatic stage and in animals, it is the main diagnostic 
tool, followed by parasite detection in the blood8. The 
pathogenic pathways are not fully understood but may involve 
several mechanisms. For example, there is the mechanism 
of  cellular injury by which active biological substances such 
as phospholipase, pyruvate, and proteases produced by live 
and dead trypanosomes are thought to cause cellular injury9. 
Immunological mechanisms have also been advanced, related 
to the removal of  erythrocytes, mostly owing to the presence 
of  autologous immunoglobulin antibodies on the red cell 
surfaces and also to cytokines, which are thought to mediate 
the loss of  erythrocytes9–12. Anaemia occurs during all stages 
of  infection, from the initial stage, which is characterised by 
high levels of  parasitaemia,13,14 to the chronic aparasitaemic 
phase, where parasites are less detectable in peripheral blood 
but tend to establish themselves in extravascular tissue. 
The recovery phase is characterised by a low presence or 
absence of  parasitaemia and the erythrocyte value returns to 
preinfection levels12.
The persistence of  anaemia beyond the initial wave of  
parasitaemia (after which low numbers of  parasites are in 
circulation) indicates that anaemia may be directly induced 
by the invasion of  red cells by parasites, and has led to a 
postulation that it might be mediated by cytokines15. Cytokines 
are important signalling molecules that, through interaction 
with other molecular messengers (such as cytokine inhibitors 
and soluble cytokine receptors), affect the behaviour of  cells 
and regulate the host immune response16. These effects 
include regulation of  inflammation, as well as control of  cell 
growth17.
A number of  studies on HAT have implicated inflammatory 
cytokines in the pathophysiology of  anaemia15,18,19, but 
the precise roles of  each individual cytokine as well as any 
variations in response between host and parasite species 
remain unclear. The aim of  this review was to assess the 
known cytokines that are implicated in trypanosome-
associated anaemia in order to guide possible biomarker 
development for the detection and management of  anaemia 
in trypanosomiasis. It is envisioned that the review may 
direct further research on other cytokines that have not yet 
been linked to trypanosome-associated anaemia but have 
been observed in trypanosomiasis. In this regard, a review 
was done on published articles, found using the PubMed 
electronic database, related to cytokines that have been 
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shown to be involved in trypanosome-associated anaemia.
Materials and Methods
The preferred reporting items for systematic reviews and 
meta-analyses (PRISMA) guidelines20 were followed in this 
review as described in the following subsections. 
Context
The focus of  this review was to identify cytokines that are 
upregulated or downregulated in trypanosomiasis and have 
been specifically shown to be associated with the anaemia 
that is observed in the course of  the disease. Trypanosomiasis 
can be caused by different trypanosome species and the host-
parasite immune response may differ from species to species. 
For the purpose of  this review, we restricted the focus to 
publications that dealt with the Trypanosoma brucei subspecies 
that cause human and animal African trypanosomiasis 
(HAT/AAT).
Search strategy and selection criteria
We conducted a literature search on the PubMed database to 
identify relevant original articles using the keywords “African 
trypanosomiasis”, “sleeping sickness”, “Trypanosoma brucei”, 
in all possible combinations with “ anaemia” and “cytokines”. 
The search was restricted to English but was neither limited 
by date of  publication nor by study design. Both human and 
animal studies were included in the search.
Initially, titles and abstracts were screened. At this stage, 
we excluded review articles and articles describing anaemia 
caused by trypanosome species other than Trypanosoma 
brucei. Articles identified as possibly relevant were retrieved 
as full papers and were further screened. The reference 
lists of  included articles were assessed for further relevant 
publications meeting our inclusion criteria. The results of  
the review are presented below.
Results
This section describes how anaemia was assessed on the 
reviewed articles and describes the role individual cytokines 
played in relation to anaemia in Trypanosoma brucei infection.
Diagnosis of anaemia in African trypanosomiasis
Most studies assessed the development of  anaemia by 
looking at the red blood cell (RBC) counts at different time 
points in experimentally infected mice, and comparing these 
counts to preinfection levels or those of  controls (uninfected 
mice)11,21,22. This assessment assumes that preinfection levels 
were normal, with anaemia being defined as a drop in RBC 
count by a specified magnitude. Other studies assessed the 
occurrence of  anaemia by comparing preinfection packed 
cell volume (PCV) of  red blood cells in mice with their PCV 
after being infected by T. brucei15,23. This assessment assumes 
that, in control mice, the percentage volume occupied by the 
red blood cells forms the normal range and therefore any 
measurements below this range are indicative of  anaemia. All 
retrieved articles reported anaemia in experimental murine 
models and no articles on human studies were retrieved.
Anaemia and cytokines
The search in the PubMed database identified 1095 potentially 
relevant articles with the selected keywords. From these 
search results, 279 articles were selected based on the titles, 
and further abstract assessment identified 23 articles suitable 
for full article review. Eleven of  the 23 articles were excluded, 
as two were reviews, six studied species of  trypanosome 
parasites other than Trypanosoma brucei, and three compared 
cytokines using parameters other than anaemia (Figure 1). 
Figure 1. Flow diagram describing different steps taken to select appropriate articles for review
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Twelve articles were finally selected for the literature review. 
A total of  eight cytokines were suspected as being involved in 
trypanosomiasis-associated anaemia. These were interferon 
gamma (IFN-γ), interleukins (IL-10, IL-6, IL-12 and IL-4), 
tumour necrosis factor-alpha (TNF/TNF-α), lymphotoxin-
alpha (LT-α), and transforming growth factor-beta (TGF-β), 
but only four were shown to be actually involved in 
trypanosomiasis-associated anaemia (IFN-γ, IL-10, TNF-α, 
IL-12). Table 1 describes the published articles, reflecting the 
cytokines studied and their involvement in anaemia. Each of  
the cytokines identified will now be described in the context 
of  their roles in Trypanosoma brucei-induced anaemia.
Interferon gamma (IFN-γ) 
IFN-γ is released by (among other immune cells) T 
lymphocytes and natural killer cells upon activation by 
specific antigens. It has potent immunoregulatory properties 
(notably macrophage activation) and antiproliferative 
effects24. It is known to inhibit bone marrow proliferation 
and has been implicated in the pathogenesis of  aplastic 
anaemia. Overexpression of  the IFN-γ gene in mice results 
in chronic anaemia. It is indicated that trypanosomiasis is 
associated with increased expression of  IFN-γ, which may 
suppress erythropoiesis and result in anaemia22,25. It is also 
suggested that suppressed erythropoiesis is a result of  
apoptosis of  haematopoetic progenitor cells11, leading to 
impaired red blood cell maturation. The increase in IFN-γ 
expression following Trypanosoma brucei brucei infection is 
associated with a rise in nitric oxide (NO)15,26, and it has been 
suggested that IFN-γ may exert its effect via NO26. Indeed, 
disruption of  the IFN-γ receptor prevents the increase in 
NO synthesis and anaemia following infection15.
IFN-γ might also contribute to anaemia through perturbation 
of  iron metabolism by upregulating expression of  the 
iron transporter DMT-1, which increases iron influx and 
sequestration into cells11,27.
Tumour necrosis factor alpha (TNF-α)
TNF-α is secreted predominantly by macrophages and is 
involved in the regulation of  a wide spectrum of  biological 
processes including cell proliferation, differentiation, 
apoptosis, lipid metabolism, and coagulation. In 
trypanosomiasis, studies suggest that it may play a crucial 
role in the pathogenesis of  anaemia, through modulation 
of  cell growth and the phagocytosis of  erythrocytes by 
macrophages28. Mice with TNF-α knockout have less severe 
anaemia and overall morbidity following trypanosomal 
infection29. The effect of  TNF-α appears to be receptor-
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specific, with TNF receptor 1 (TNF-R1) associated with 
severe anaemia, but not TNF-R230. It is important to note 
that, in mice, TNF-α deficiency was only protective of  
anaemia following Trypanosoma brucei brucei infection but not 
with Trypanosoma congolense infection15, suggesting that the 
TNF-α host-parasite combination is critical in determining 
the effects of  TNF-α on anaemia.
Interleukin 10 (IL-10)
Several articles indicated that IL-10 works in concert with other 
cytokines in trypanosomiasis-associated anaemia11,21–23. IL-10 
has been shown to downregulate the production of  IFN-γ 
and TNF-α by classically activated (M1) macrophages21,31. 
Thus, the balance between IL-10 and IFN-γ or IL-10 and 
TNF-α appears to be a critical determinant of  the severity of  
anaemia associated with trypanosomiasis11,22,23. These articles 
also presented data suggesting that IL-10 might be protective 
against anaemia, as IL-10 knockout (IL-10-/-) mice exhibit 
severe anaemia, in addition to other pathological features 
such as neurologic symptoms and systemic inflammation26.
There is also evidence that IL-10 may have an influence 
on iron uptake. For example, one study showed that the 
changes in mRNA levels of  transferrin (Tf)—the universal 
transporter of  iron (Fe3+)—during the different phases of  
trypanosomal infection closely paralleled those of  IL-10 
expression25.
Interleukin 12 (IL-12)
There was only one article that reported a relationship 
between IL-12 and anaemia in trypanosomiasis. In this study, 
BALB/c mice were infected with either strain 927 or strain 
247 of  Trypanosoma brucei. Infected mice were associated with 
increased levels of  IL-12 compared to uninfected mice at all 
time points for both parasite strains, with levels in IL-12 in 
strain 247-infected mice being greater than those in strain 
927-infected mice22.
Discussion
Cytokines play a number of  roles in biological processes 
and have been implicated in the pathogenesis of  several 
disorders, notably immunoinflammatory conditions. In 
HAT, trypanosomes trigger a strong cytokine response with 
a type I immune response during the early stage, followed by 
a type II cytokine response in the late, chronic phase11,32. This 
type I/type II switch is considered important in controlling 
the severity of  the disease. It is detrimental for the host to 
be locked in one type of  cytokine environment throughout 
the infection. Here, we reviewed published data on the role 
cytokines play in immunopathology leading to anaemia in 
trypanosomiasis.
The literature search yielded 12 articles, which reported 
eight different cytokines that were thought to be involved in 
anaemia associated with Trypanosoma brucei infection. Of  the 
eight cytokines, four were shown to play a key role, either by 
increasing the severity of  anaemia or attenuating it. Those 
associated with more severe disease were TNF-α, IFN-γ 
and IL-12, all of  which classically have proinflammatory 
properties. In contrast, IL-10, which is an anti-inflammatory 
cytokine, was shown to reduce the severity of  anaemia.
Most studies identified TNF-α and IFN-γ as key cytokines 
that play greater roles in trypanosomiasis-associated 
anaemia, with each cytokine being reported in 10 of  the 
12 articles that qualified for the review. These data showed 
that the early stage of  infection has been characterised by 
significant upregulation of  TNF-α and IFN-γ. Prolonged 
overexpression of  TNF-α correlated with disease severity 
(including anaemia and cachexia)33, and extended survival 
of  the host, dependent on the changes of  cytokine profile 
towards anti-inflammatory ones, such as IL-10. IL-10 was 
also commonly cited; it was reported in eight of  the articles 
that were reviewed. High levels of  IL-10 were shown to 
down-regulate TNF-α and to attenuate the severity of  the 
anaemia.
The molecular details of  how cytokines mediate their effects 
to influence the severity of  anaemia are largely unknown. 
However, a number of  studies in mice have implicated 
NO as a key mediator of  the cytokine response. NO is a 
pivotal effector molecule and possesses both cytostatic and 
cytolytic properties, as observed in Trypanosoma congolense 
infection34. Sternberg and Mabbot demonstrated that 
anaemia in the murine model was mediated by suppressor 
macrophages releasing nitric oxide. In in vitro studies, they 
recorded NO-dependent suppression of  T cell proliferation 
when splenocyte cultures were exposed to IFN-γ and 
trypanosomes, similar to the characteristic suppression 
seen in the spleen of  trypanosome-infected mice, therefore 
suggesting the role of  NO in IFN-γ-associated anaemia35. 
Similar studies by the same authors have demonstrated 
the relationship between anaemia and bone marrow NO 
production, with bone marrow cell populations from 
Trypanosoma brucei-infected mice exhibiting increased levels 
of  NO synthase activity, while suppression of  bone marrow 
T cell proliferation coincided with NO production. It was 
therefore postulated that increased NO production in the 
bone marrow of  Trypanosoma brucei-infected mice was 
probably playing a significant role in the anaemia resulting 
from Trypanosoma brucei infection10. In these studies, the 
authors also reported a correlation between serum nitrate 
concentrations and rising parasitaemia in Trypanosoma brucei-
infected mice, in whom a 50% reduction in erythrocyte 
count and lowered haemoglobin concentrations were also 
noted. However, these conditions were reversed when 
infected mice were treated with NG-nitro-L-arginine methyl 
ester (L-NAME), an inhibitor of  NO synthesis, prompting 
a postulation that NO may be acting on the proliferation of  
immature erythrocytes or haematopoetic stem cells, resulting 
in anaemia10.
Another potential mechanism explaining the effects of  
cytokines on anaemia might involve regulation of  iron 
metabolism. Stijlemans et al.  showed that bone marrow iron 
levels decline during the course of  Trypanosoma brucei infection, 
and that this affects erythropoesis27; the total amount of  
erythrocytes isolated using a marker based on cell-surface 
erythroid-specific Ter 119 antigen and transferrin receptor 
(CD71) showed a significant drop in infected animals as 
compared to uninfected animals at the bone marrow level27. 
Additionally, trypanosomiasis may induce anaemia through 
the direct destruction of  red cells infected by the parasites. 
For example, goats experimentally infected with T. congolense 
and T. brucei exhibit increased destruction of  erythrocytes in 
the blood by the infecting trypanosomes, leading to reduced 
haemoglobin levels, despite increased erythrogenesis in 
response to increased erythrocyte loss36.
These data and interactions indicate anaemia associated 
with trypanosomiasis results from a cascade of  responses. 
It is evident that there is a need for a holistic approach to 
gain a better understanding of  the aetiological factors. 
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Moreover, the role of  any particular cytokine or factor in the 
pathogenesis of  anaemia during trypanosomiasis appears to 
be dependent on the host as well as the parasite itself.
No human data were retrieved in this review therefore the 
generalisation of  the findings to human disease should be 
made with great caution, even if  there is a 95% genomic 
level of  identity between mice and humans37. Future 
understanding on the pathogenesis of  anaemia in human 
African trypanosomiasis would be better informed by 
human-based studies.
Conclusion
The objective of  this review was to investigate the published 
data regarding the role certain cytokines play in the 
immunopathology leading to anaemia in trypanosomiasis 
disease. The PubMed database was searched and articles were 
included using the PRISMA method. Though the search 
yielded many articles on trypanosomiasis, few reported on 
cytokines associated with anaemia in trypanosomiasis. This 
could be as a result of  the limitation of  this review, as it 
only focused on cytokines involved in anaemia caused by 
Trypanosoma brucei, the only species known to cause human 
and animal African trypanosomiasis. This restriction was 
based on the fact that trypanosomiasis is caused by different 
trypanosome species and the host-parasite immune responses 
may differ from species to species.
The immune responses associated with anaemia in Trypanosoma 
brucei infection include upregulation or downregulation of  
cytokines. Three cytokines (IL-10, TNF-α and IFN-γ) have 
been shown to play an important role: the IL-10 acting to 
counter the effects of  the two proinflammatory cytokines, 
TNF-α and IFN-γ, to reduce the severity of  the disease. The 
cytokines appear to work in concert with other regulatory 
pathways, notably nitric oxide and regulators of  iron 
metabolism, to mediate their effects on bone marrow and 
circulating erythrocytes. Further research is recommended 
to explore other cytokines that might be involved in this 
cascade and to gain a better understanding of  the processes 
involved.
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